Regeneron Pharmaceuticals, INC. — 13F Holdings

2026 Q3  ·  3 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, REGENERON PHARMACEUTICALS, INC. maintained a portfolio of 3 distinct positions.
Position History hover any row below to update
Loading…
REGENERON PHARMACEUTICALS, INC. Tarrytown, NY Operating Company AUM $180M
PCA Score Concentration Risk
Risk ENB
Total Positions
3
Quarter
2026 Q3
Top Holding
PBLS (74.9%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-3 of 3

REGENERON PHARMACEUTICALS, INC. Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
PBLS
Parabilis Medic...
Healthcare 74.90% 64.35% #1
Prev: #1
7.0
—
no change no change
P
S
4,166,666 $134,541,645
$27.37 +5.6%
$32.29 -10.5%
2026 Q2 13F Filing 2026-09-30 2026-11-05
NTLA
Intellia Therap...
Healthcare 24.86% 35.35% #2
Prev: #2
6.5
—
no change no change
P
S
3,702,995 $44,658,120
$11.66 -16.1%
$12.06 -18.9%
2024 Q4 13F Filing 2026-09-30 2026-11-05
ACET
Adicet Bio, Inc...
Healthcare 0.24% 0.30% #3
Prev: #3
2.1
—
no change no change
P
S
60,511 $432,049 2024 Q4 13F Filing 2026-09-30 2026-11-05
Showing 1-3 of 3 holdings

Unlock Full REGENERON PHARMACEUTICALS, INC. Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →